Transinsight Wins FutureSAX VC-Forum for Best Company

TransinsightFutureSAX invited venture capitalists and entrepreneurs from all over Germany to Dresden under the motto "Lift Off with Venture Capital - Emphasis on Technology and Environment." In front of 80 guests, among them 30 investors, the jury selected Transinsight with its software technology for knowledge-based information searches from seven finalists as the winner of the most promising investment.

"The jury choose the Transinsight team because of their excellent business concept and investment, as well as their convincing presentation", says futureSAX representative Kerstin Trautmann. She goes on to say: "the Businessplan-Wettbewerb Sachsen GmbH congratulates the winner for this outstanding success."

"We are proud our concept is regarded as outstanding by top-class investors", says Dr. Michael R. Alvers, CEO of Transinsight GmbH. He continues: "We created software with the potential to revolutionize information searching. Themed "Together we Search, Think, and Write", we raise searching to a new level. We do not rank search results, the user does! This fosters democracy and allows companies and others to save plenty of time, which then becomes available for other relevant tasks."

Mark Miller, CEO of CatCap and a member of the jury, is convinced that close cooperation between the university and new high-tech companies in Dresden will lead to success. "Transinsight GmbH, with its brand new search paradigm, is well-positioned in the rapidly growing information handling and knowledge management market," says Miller.

Related news articles:

About Transinsight
Founded in 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge-based technologies. The flagship product, www.gopubmed.com, a well established biomedical search engine, is the first knowledge-based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technical University Dresden. For further information, visit www.transinsight.com.

About the VC Forum futureSAX
FutureSAX hosted a venture capital forum near the Frauenkirche for intensive discourse between venture capital investors. This forum has been the only VC networking forum to date in Saxony. Companies in the fields of technology and environment from all over Germany looking for investors could apply for one of eight presentation slots. FutureSAX was supported by KPMG and 3i Deutschland GmbH as well as by cooperation partners CatCap GmbH, Neuhaus Partners GmbH, and F.A.Z.-Institut GmbH. Investors were given the chance to get to know different outstanding companies during a single day as well as to get in contact with many potential co-investors. Companies were given the opportunity to present themselves in front of a community of investors. After the presentations, companies and investors got together over refreshments for one-on-one discussions. For further information, visit www.futuresax.de.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Model Converts Hospital Records into …

UCLA researchers have developed an AI system that turns fragmented electronic health records (EHR) normally in tables into readable narratives, allowing artificial intelligence to make sense of complex patient histories...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Mayo Clinic's AI Tool Identifies 9 …

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...